Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |